The Wesley Medical Research Board, chaired by Mr Peter Allen, consists of highly qualified, skilled and dedicated men and women who not only govern the organisation but are actively committed to fundraising for medical research.
Mr Peter Allen, Chairman
A WMR director since 2005, Peter Allen is a former partner in and consultant to national law firm Allens Linklaters and is a Notary Public. He is currently Chair of Bio Pharmaceuticals Australia Pty Ltd, Nucrush Group and Riverside Marine Group, and a Director of Ensham Workers Entitlement Fund Pty Ltd. In the community, he is a past president of the MS Society of Queensland, past chair of the Revenue Law Committee of the Queensland Law Society and a former member of a Human Research Ethics Committee.
A/Prof John Allan
A/Prof John Allan has been an obstetrician and gynaecologist VMP at The Wesley Hospital since 1984. He is the Chief Academic Medical Officer of UnitingCare Health and Head of the UnitingCare Health Clinical School. He has a strong interest in research and developed the IVF clinic at The Wesley Hospital in 1988. He is a Clinical Consultant for Cook Medical and is the Chair of the Human Research Ethics Committee.
Dr Jim Aylward
Dr Jim Aylward holds a PhD in Biochemistry from Monash University and worked in medical research labs in the US for 5 years, before joining CSIRO. He founded his own biotech-drug-development company, Peplin, in 1998, based on his own IP. Peplin Ltd was acquired by Leo Pharma A/S in 2009 for USD287.5m.
Dr Aylward has continued to help small tech startups in a mentoring capacity through iLab in Toowong (2004-2010) and the Mentoring for Growth program (Queensland Government). He was an assessor for the Australian Technology Showcase (2009-2012). Dr Aylward was joint winner of the 2012 LSQ Excellence award, in recognition of his contribution to the life sciences industry.
Mr Peter Crowley
Peter is a highly experienced business leader and public company director with 15 years’ experience leading public companies and 17 years’ experience serving on public company boards both in Australia and overseas. His international business experience covers diverse industries including construction materials, building products, mining, transport, industrial chemicals and automotive components. From early 2003 until his retirement in late 2015, Peter led GWA Group Limited. Peter also served on the Business Council of Australia from 2009 until his retirement.
Dr Dickinson has been an orthopaedic surgeon at the Wesley Hospital for over 25 years. His major clinical and research interest has been in orthopaedic oncology.
He has been Chairman of the Medical Advisory Committee and Board Member at the Wesley Hospital, Vice President of the Royal Australasian College of Surgeons and President of the Australian Orthopaedic Association.
He has also served as an examiner for the Royal Australasian College of Surgeons, as Chairman of the Queensland Branch of the Australian Orthopaedic Association, Chairman of the Orthopaedic Department of Princess Alexandra Hospital, and as Trustee of the Queensland Orthopaedic Research Trust. He serves on the Wesley Research Committee, and is an editorial board member and reviewer of a number of journals.
He has a keen interest in classical music, opera, golf and sailing.
Professor MaryLou Fleming is Head of School of Public Health and Social Work at the Queensland University of Technology. She has experience in University administration, teaching and research in higher education and public health and health promotion for over twenty five years.
She has been a member of Boards such as the St Andrew’s Hospital Board and Research Institute, the Board of the National Heart Foundation in Queensland and Health Promotion Queensland and Chair of the Quality Management Committee for Breastscreen Queensland. She has been a panel member for NHMRC project grants and the National Endeavour Awards selection panel. She is a member of the Public Health Association of Australia.
She has undertaken and completed a range of program and policy evaluations and workforce analysis and translational research in community and school settings, for non-government organisations, the Queensland Health Department, the Commonwealth Department of Health and the NHMRC. She has undertaken consultancy work for the WHO on public health in Vietnam and the South Pacific.
Deborah has extensive experience and expertise as a Chief Financial Officer (CFO) for listed companies in a range of industries.
She was appointed as QR National’s Chief Financial Officer in December 2007 after a career that included 20 years in the mining industry. She was CFO of MIM Holdings Limited for six years and is a former CFO of Queensland Cotton. Deborah was a Director and Chair of the Audit Committee for CSIRO up until May 2011.
She is a former Director of companies including Norfolk Group Ltd and has served as a member of the Queensland Biotech Advisory Council, the Workers Compensation Board of Queensland, Queensland Country Health Society and subsidiary companies of MIM Holdings Ltd including overseas corporations. She is currently a member of the Advisory Committee for the Banking and Finance School of the Queensland University of Technology.
Professor David Paterson
Professor David Paterson is an Infectious Diseases Physician and Professor of Medicine at the University of Queensland Centre for Clinical Research. He is the author of 350 peer-reviewed publications and more than 20 book chapters. He has practiced medicine and conducted clinical research in Australia, the United States and Europe, and has given invited lectures in 30 countries. He was the AMA’s Bancroft Orator for 2013.
Professor John Fraser
Professor John Fraser is a graduate of the University of Glasgow where he received fellowships in Medicine and Anaesthesia during his basic ICU training. He completed his ICU training in Brisbane prior to his PhD on burns and smoke inhalation injury through University of Queensland.
He is a pre-eminent Intensivist at The Prince Charles Hospital, where he founded and heads the multi disciplinary Critical Care Research Group, the largest group of its kind in Australasia. In 2014 the group was awarded The Centre for Research Excellence (one of only of six clinical CRE’s) in Australasia looking at the development and utilisation of bionic hearts and lungs, collaborating throughout Australia, Japan, Singapore, Malaysia and China.
He is the Director of ICU at St Andrew’s War Memorial Hospital, Brisbane, and has 5 professorial appointments, currently supervising over 20 PhD, MPhil and honours students in medicine, surgery, basic science, engineering and allied health fields across 7 laboratories. He has published over 250 peer-reviewed papers and multiple book chapters.
Dr Christine Foley
Dr Christine Foley commenced as the Director of Clinical Governance with UnitingCare Health in December, 2016. She worked in senior leadership roles within Catholic health and aged care for the past 11 years, gaining a unique perspective from working in private not-for-profit health and aged care settings as a nursing leader. Prior to this, she worked as a senior nursing leader at the Princess Alexandra Hospital as an Assistant Director of Nursing. Her key areas of interest include:
- Quality & safety systems linked to evidence-based clinical and management decision making, quality indicators and quality monitoring towards continuous improvement in health care.
- Integrated systems in clinical quality and safety linked to leadership and management models.
- Policy and practice approaches to reflexively dealing with complexity in healthcare systems.
- Integration of Translational Research Evidence and Practice.
Mr Charlie Sartain
Charlie Sartain joined the WMR Board in 2009. A leading Queensland-based mining industry figure, Charlie has more than 30 years’ experience in the Australian and global mining industry. In the earlier part of his career, Charlie had extensive executive experience with MIM Holdings Limited, culminating in his appointment as its most senior executive in Latin America. After the takeover of that company by Xstrata PLC in 2003, he then spent nine years as CEO of Xstrata’s global copper business, with operations and projects spanning eight countries.
He is currently a Non-Executive Director on the Boards of ASX-listed companies ALS Limited and Austin Engineering Limited. He also has board roles with the University of Queensland as a Member of the UQ Senate and Chairman of the Advisory Board of the Sustainable Minerals Institute.
Mr Arthur Yannakou
Arthur Yannakou is Group Executive, UnitingCare Health. As a General Manager and Chartered Accountant, Arthur has over 25 years international operational experience, involving senior leadership positions in non-profit, faith-based organisations, as well as in public and private companies, in Australia, the United Kingdom and South Africa.
He has held CEO, National/Regional/General Manager and Finance Manager positions within the private health care service industry and has a strong track record working in a mission led organisation, such as The Little Company of Mary Health Care (LCMHC). Arthur’s most recent role, as National Director Private Hospitals at LCMHC; involved leading a group of 11 private hospitals and 2 day surgeries.